𝐾ちゃん ❤︎(@K_chanV3) 's Twitter Profile Photo

普段たべすぎなせいか
リベルサス3じゃ効かねえぇぇぇえ!!
やっぱ注射がきくんだよな
楽天カードで詰んだGLP1

account_circle
Gizem Kaya(@GizemKaya_MD) 's Twitter Profile Photo

Check our study about one of the most hot topic of not just gastroenterology but whole medicine❗️❗️❗️
Gastroparesis risk in patients with type 2 diabetes prescribed GLP-1 receptor agonists Osama Hamid Miguel Regueiro

Check our study about one of the most hot topic of not just gastroenterology but whole medicine❗️❗️❗️
Gastroparesis risk in patients with type 2 diabetes prescribed GLP-1 receptor agonists #ddw2024 #plenarysession #gastroparesis #GLP1 #type2diabetes @OsamaHamidMD @MRegueiroMD
account_circle
Phyteau(@Phyteau) 's Twitter Profile Photo

'The new obesity drugs work, but it's a dilemma when people have to stop taking them'

For whatever reason you stop taking them, side-effects, cost, availability, safety, etc, we have a safe, effective alternative solution 4 you.

npr.org/2024/05/27/nx-…

account_circle
Cardiac Trials(@CardiacTrials) 's Twitter Profile Photo

GLP1 agonism in obesity to reduce CV mortality? This trial showed reduced MI/stroke in prior CVD and high BMI, in the absence of diabetes. A practice-changing trial establishing obesity as a modifiable risk factor for CVD. SELECT Trial, NEJM 2023 ♥️

GLP1 agonism in obesity to reduce CV mortality? This trial showed reduced MI/stroke in prior CVD and high BMI, in the absence of diabetes. A practice-changing trial establishing obesity as a modifiable risk factor for CVD. SELECT Trial, NEJM 2023 ♥️
account_circle
Dr. Tracy A. Pearson, JD ⚖️🎥📺🎤(@TracyExplains) 's Twitter Profile Photo

̊ Wegovy is for weight loss. Ozempic is for diabetes. I'm struck by diabetics who are causing a shortage for people who are obese and for whom the FDA approved Wegovy.

GLP1 is a hormone in your body. Long term damage comes from abuse, as with any drug taken for no reason or taken

account_circle
Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦(@pabeda1) 's Twitter Profile Photo

what are the Putative mechanism of renal protection attributed to GLP1 agonists? Whatever they are, just published has confirmed the ⬇️ in kidney endpts & MACE3 & all cause ☠️ w/semaglutide in DM+albuminuria

#EASCongress2024  #CardioTwitter #MedTwitter #Cardiology #CardioEd what are the Putative mechanism of renal protection attributed to GLP1 agonists? Whatever they are, #Flow just published has confirmed the ⬇️ in kidney endpts & MACE3 & all cause ☠️ w/semaglutide in DM+albuminuria
account_circle
Obesity Canada - Obésité Canada(@ObesityCan) 's Twitter Profile Photo

Hot off the presses! Semaglutide protects kidneys and saves lives in people with type 2 diabetes and chronic kidney disease. Read more by Dr. Sue buff.ly/4aAPEOn

Hot off the presses! Semaglutide #ozempic protects kidneys and saves lives in people with type 2 diabetes and chronic kidney disease.  Read more by Dr. Sue buff.ly/4aAPEOn
account_circle
Ordoscopie(@Ordoscopie) 's Twitter Profile Photo

💡 Tableau comparatif entre les agonistes GLP1 et les inhibiteurs du SGLT2

👉 drive.google.com/file/d/1Vy5cR9…

💡 Tableau comparatif entre les agonistes GLP1 et les inhibiteurs du SGLT2

👉 drive.google.com/file/d/1Vy5cR9…
account_circle
John Tal(@JohnTal6) 's Twitter Profile Photo

Semaglutide und Liraglutide (zbsp Ozempic) sind GLP1 Agonisten die den Blutzucker senken und zusätzlich den Appetit hemmen.

Da gerät gerade etwas ziemlich aus den Fugen. Das kann NICHT die Lösung sein für die weltweite Adipositas Epidemie

clinicaltrials.gov/study/NCT04775…

Semaglutide und Liraglutide (zbsp Ozempic) sind GLP1 Agonisten die den Blutzucker senken und zusätzlich den Appetit hemmen.

Da gerät gerade etwas ziemlich aus den Fugen. Das kann NICHT die Lösung sein für die weltweite Adipositas Epidemie

clinicaltrials.gov/study/NCT04775…
account_circle